Edwards Lifesciences: Heart Failure trials

The registry lists 14 Heart Failure studies with Edwards Lifesciences as lead sponsor. 4 are open to participants now and 3 have results posted.

No phase 14(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Early Feasibility Study of the Edwards APTURE Transcatheter Shunt SystemRecruitingNCT07858799Not applicable
• Real World Effectiveness of the Cordella Pulmonary Artery Sensor System in Patients With Chronic Heart Heart FailureRecruitingNCT06783335
• PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and IIIRecruitingNCT05934487Not applicable
• Early Feasibility Study - Edwards APTURE Transcatheter Shunt SystemRecruitingNCT03523416Not applicable
• PROACTIVE-HF IDE Trial Heart Failure NYHA Class IIIActive, not recruitingNCT04089059Not applicableResults posted
• PARTNER 3 Trial - Mitral Valve in ValveActive, not recruitingNCT03193801Not applicableResults posted
• ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)CompletedNCT01757665Not applicableResults posted
• ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt SystemActive, not recruitingNCT05686317Not applicable
• ExplorATory Study oF the EdWards Transcatheter Atrial Shunt System (AlT FloW Germany)WithdrawnNCT04965623Not applicable
• TRISCEND II Pivotal TrialActive, not recruitingNCT04482062Not applicable
• SIRONA 2 Trial Heart Failure NYHA Class IIIActive, not recruitingNCT04012944Not applicable
• Exploratory Study of the Edwards APTURE Transcatheter Shunt System (ALT-FLOW Canada)Active, not recruitingNCT04000607Not applicable
• PRODIGY Registry in NYHA Class III Heart Failure PatientsTerminatedNCT03623165
• SIRONA Trial Heart Failure NYHA Class IIICompletedNCT03375710Not applicable